Director ZHANG Changxi's clinical experience in the treatment of interstitial lung disease
The course of interstitial lung disease is long,and the symptoms vary according to the different stages of the disease development.Director ZHANG Changxi believes that the disease should be diagnosed as two diseases according to the different pathological stages.In the early stage of the disease,it should be diagnosed as lung arthralgia mainly due to extemal pathogenic invades lung,Qi(气)and blood ob-struction,which manifests as cough and chest tightness.And with the obstruction of pathogenic factors in the lung for a long time,it causes Qi and Yin(阴)deficiency,and combines with sweating because of labor,which leads to the body fluid deficiency,lung fails to be nourished,which in tum can not promote the Qi of the viscera,and when the lung is weak and not used,it can be called lung impotence.Therefore,in the course of treating this disease,Director ZHANG proposes"Staged treatment".At the same time,attention should also paid to the principle of"Urgent treatment of the symptoms and slow treatment of its root causes",the different pathological stages of the disease also have their own focuses,in the treatment of symptoms,the focus is on removing extemal pathogenic factors,at the same time,the treatment should also remove blood stasis and phlegm,promoting blood circulation,in the treatment of the root causes,attention should be given to tonify lung and kidney,Qi and spleen.According to the different characteristics of different stages of the disease,the combination of disease differentiation and syndrome differentiation,the combination of traditional Chinese medicine and Westem med-icine,and the optimization of treatment according to their own characteristics should be achieved.Interstitial lung disease is a refractory disease.The use of syndrome differentiation in TCM treatment can not only improve the quality of life of patients,but also relieve the symptoms of patients.Traditional Chinese medicine has obvious advantages in the treatment of interstittial lung disease,which can not only improve the clinical efficacy,but also regulate the collective immune function,and can significantly improve the quality of life of patients.
万方数据
维普
